Precision Neuroscience

Builds thin-film brain-computer interface implants that read and stimulate neural activity from the brain surface for patients with paralysis.

View on the globe

$250MEquity raised in 2025–20262025 — · 2026 $250M · 1 equity round
$250MEquity raised, all time1 equity round sourced so far
—Latest valuationnot disclosed

Rounds over time log-scaled amounts

Funding history: 1 round from 24 Sep 2026 to 24 Sep 2026, $250M equity disclosed. Earlier rounds exist but are not sourced.24 Sep 2026: Series D, $250M$10M$30M$100M$300M$1BEarlier rounds exist but are not sourced yet← earlier rounds not sourcedest. 2021Q2Q3Q42027Q2Equity round24 Sep 2026 · Series D · $250M · led by Pershing Square, Ackman Oxman InstituteSeries D · $250M
Funding history: 1 round from 24 Sep 2026 to 24 Sep 2026, $250M equity disclosed. Earlier rounds exist but are not sourced.24 Sep 2026: Series D, $250M$10M$30M$100M$300M$1BEarlier rounds exist but are not sourced yetearlier rounds not sourced’21Q2Q3Q42027Q2Equity round24 Sep 2026 · Series D · $250M · led by Pershing Square, Ackman Oxman Institute$250M

Funding history 1 round · 3 sources

Earlier rounds not yet sourced. Precision Neuroscience was founded in 2021 and raised before 24 Sep 2026; only the rounds below are sourced so far, so its all-time equity total understates its history.

  1. Series D
    Amount$250M
    Post-money—
    ✓ Confirmed
    Lead
    Pershing Square, Ackman Oxman Institute
    Also
    Duquesne Family Office, B Capital, ARK Invest, Invus, Mubadala, Mirae Asset, Korea Investment Partners, Hitachi, JSL Health Capital
    Note
    Co-led by Pershing Square, the Ackman Oxman Institute and an undisclosed life sciences fund. Total raised about $430M. Valuation reported by the NYT via The Next Web as just over $1B, not labeled post-money, so left null. Earlier rounds not sourced here.
    Sources
  2. Earlier rounds not yet sourced

Investors 11

  • Ackman Oxman Institute1
  • Pershing Square1
  • ARK Invest
  • B Capital
  • Duquesne Family Office
  • Hitachi
  • Invus
  • JSL Health Capital
  • Korea Investment Partners
  • Mirae Asset
  • Mubadala

Highlighted investors led at least one equity round; the number is equity rounds taken part in.

Related companies shared investors

Also in the New York hub see on the globe

Figures in USD at the time of each round. See the methodology for how rounds are sourced and verified. Precision Neuroscience and its logo are trademarks of their owners, used here for identification only.